Hata Yujiro S insider trades
Hata Yujiro S has filed 20 Form 4s with the SEC that we hold, for IDEAYA Biosciences, Inc. (IDYA) (President and CEO, Director), Enanta Pharmaceuticals INC (ENTA) (Director) and Xencor Inc (XNCR) (Director). Across all of them we count 0 purchases worth $0 and 16 sales worth $18.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($985.4K). The largest single trade was a sale of 75,815 shares of IDEAYA Biosciences, Inc. worth $3.4M, dated 2024-02-08. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-23 and the latest 2026-10-08.
IDEAYA Biosciences, Inc. (IDYA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-15 | S, sale reported on Form 4 | 75,000 | $2.6M | 2023-12-19 |
| 2024-01-12 | S, sale reported on Form 4 | 12,261 | $490.9K | 2024-01-17 |
| 2024-01-16 | S, sale reported on Form 4 | 62,739 | $2.5M | 2024-01-17 |
| 2024-02-01 | S, sale reported on Form 4 | 4 | $180 | 2024-02-05 |
| 2024-02-01 | S, sale reported on Form 4 | 624 | $28.1K | 2024-02-05 |
| 2024-02-08 | S, sale reported on Form 4 | 75,815 | $3.4M | 2024-02-12 |
| 2024-02-09 | S, sale reported on Form 4 | 23,557 | $1.1M | 2024-02-12 |
| 2024-05-14 | S, sale reported on Form 4 | 54,408 | $2.3M | 2024-05-16 |
| 2024-05-14 | S, sale reported on Form 4 | 2,303 | $96.4K | 2024-05-16 |
| 2024-05-15 | S, sale reported on Form 4 | 53,592 | $2.3M | 2024-05-16 |
| 2024-05-15 | S, sale reported on Form 4 | 29,761 | $1.3M | 2024-05-16 |
| 2024-05-15 | S, sale reported on Form 4 | 503 | $22.2K | 2024-05-16 |
| 2024-05-16 | S, sale reported on Form 4 | 4,349 | $184.3K | 2024-05-16 |
| 2024-05-16 | S, sale reported on Form 4 | 30,084 | $1.3M | 2024-05-16 |
| 2026-10-06 | S, sale reported on Form 4 | 25,538 | $954.8K | 2026-10-08 |
| 2026-10-06 | S, sale reported on Form 4 | 800 | $30.6K | 2026-10-08 |
Enanta Pharmaceuticals INC (ENTA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Xencor Inc (XNCR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1649119) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms